0001892756-21-000001.txt : 20211118 0001892756-21-000001.hdr.sgml : 20211118 20211118154249 ACCESSION NUMBER: 0001892756-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211118 DATE AS OF CHANGE: 20211118 EFFECTIVENESS DATE: 20211118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eutropics Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001892756 IRS NUMBER: 202971708 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-421693 FILM NUMBER: 211424218 BUSINESS ADDRESS: STREET 1: 767 CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 617-714-4405 MAIL ADDRESS: STREET 1: 767 CONCORD AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 D 1 primary_doc.xml X0708 D LIVE 0001892756 Eutropics Pharmaceuticals, Inc. 767 CONCORD AVENUE CAMBRIDGE MA MASSACHUSETTS 02138 617-714-4405 DELAWARE None None Corporation true Michael Cardone 767 Concord Avenue Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2021-11-03 false true true false 0 2000000 350000 1650000 false 5 0 0 0 true false Eutropics Pharmaceuticals, Inc. /s/ Michael Cardone Michael Cardone CEO 2021-11-18